Fig. 5
Kaplan–Meier analysis of disease-free survival and overall survival according to the nomogram-predicted subgroups of all patients. a Disease-free survival of all patients in the high- and low-probability LNM subgroups. b Overall survival of all patients in the high- and low-probability LNM subgroups. LNM lymph node metastasis, HR hazard ratio, CI confidence interval